Merck: Merck granted EC approval for adult-specific pneumococcal vaccine Capvaxive
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease
Read full article »
Merck is a New Jersey-based multinational biopharmaceutical company that develops and commercializes novel therapeutics and vaccines for the treatment of a range of diseases.
Read more